Umesh Pharmaceuticals Private Limited
About Umesh Pharmaceuticals Private Limited
Data last updated:
Umesh Pharmaceuticals Private Limited was a private limited company based in New Delhi, Delhi, India. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 03 August 2004.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2004PTC128051.
The company had an authorised share capital of ₹75 Lakh and a paid-up capital of ₹74.06 Lakh. It was led by directors Prabhat Kumar Srivastava and Riya Srivastava.
Its last annual general meeting (AGM) was held on 25 September 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office was at C – 30 Panchsheel Enclave, New Delhi, Delhi, India – 110017.
Court records list 1 case involving the company, including 1 filed by the company.
Company details
Contact details
Umesh Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressC – 30 Panchsheel Enclave, New Delhi, Delhi, India – 110017
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Umesh Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Umesh Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
Financials of Umesh Pharmaceuticals Private Limited
FY 2021 filings availableFinancial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Umesh Pharmaceuticals Private Limited, buy the company report.
Board of directors of Umesh Pharmaceuticals Private Limited
Umesh Pharmaceuticals has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prabhat Kumar Srivastava Also directs: Rock Land Private Limited, Rockland Hotels Limited, Rockland Hotels Rudrapur Private Limited and 1 more | Director | 13 Sep 2018 | 8 Years 1 Months | As last reported |
| Riya Srivastava | Director | 23 Feb 2012 | 14 Years 8 Months | As last reported |
Auditor
Umesh Pharmaceuticals Private Limited is audited by A K N B M & COMPANY for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A K N B M & COMPANY | FY 2018 | 028887N |
Shareholding
The shareholding of Umesh Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Umesh Pharmaceuticals Private Limited, buy the company report.
Legal cases
Umesh Pharmaceuticals Private Limited has 1 court case on record: 1 filed by Umesh Pharmaceuticals. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Writ petition | Filed by the company against Income Tax Settlement Commission, & Ors. | Disposed |
To see the full case history of Umesh Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Umesh Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Umesh Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Umesh Pharmaceuticals Private Limited has 6 board changes on record since 2012: 2 appointments and 4 cessations. The latest: Prabhat Kumar Srivastava ceased to be Additional Director on 29 Sep 2018.
Frequently asked questions
Umesh Pharmaceuticals has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Umesh Pharmaceuticals was a private limited company based in New Delhi, Delhi, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 03 August 2004 and is registered under CIN U24232DL2004PTC128051. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Umesh Pharmaceuticals was incorporated on 03 August 2004. It is registered with the Registrar of Companies, Delhi.
Umesh Pharmaceuticals had 2 directors:
- Prabhat Kumar Srivastava - Director
- Riya Srivastava - Director
The CIN (Corporate Identification Number) of Umesh Pharmaceuticals is U24232DL2004PTC128051. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Umesh Pharmaceuticals is at C – 30 Panchsheel Enclave, New Delhi, Delhi, India – 110017.
The latest financial statements of Umesh Pharmaceuticals on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 25 September 2021. Year-wise statements from 2015 are in the company report.
Umesh Pharmaceuticals operated in the pharma industry, in the drug formulation and development segment.
Umesh Pharmaceuticals has 1 court case on record: 1 filed by the company.
Prabhat Kumar Srivastava ceased to be Additional Director on 29 Sep 2018. Ravinder Sharma ceased to be Director on 15 Sep 2018. Prabhat Kumar Srivastava was appointed as Director on 13 Sep 2018. Umesh Pharmaceuticals has 6 board changes on record in total.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
